INNOVENT BIO

Forecast & Rating30 analysts currently cover INNOVENT BIO, with about 93.3% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$129.12, about 39.4% upside from the current price of HK$92.60. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 66.8% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study INNOVENT BIO closely still see room for the stock to rise. Data as of Sep 30, 2026; for reference only and not investment advice.